KAWASE, K.; YOSHIDA, K.; HARA, K.; HIDAKA, S.; TAKEYAMA, H. Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer. Clinical Medicine Insights, [S. l.], v. 4, n. 2, p. 378–386, 2023. DOI: 10.52845/CMI/2023-4-2-1. Disponível em: http://medicineinsights.info/index.php/cmi/article/view/179. Acesso em: 20 nov. 2024.